Pleasant Valley, NY, United States of America

Kenneth S Graham

USPTO Granted Patents = 25 

 

 

Average Co-Inventor Count = 3.7

ph-index = 12

Forward Citations = 673(Granted Patents)


Company Filing History:


Years Active: 2009-2025

Loading Chart...
Loading Chart...
Loading Chart...
25 patents (USPTO):Explore Patents

Introduction

Kenneth S. Graham is a distinguished inventor residing in Pleasant Valley, NY. With an impressive portfolio of 22 patents, he has made significant contributions to the field of ophthalmology. His innovations focus on advanced treatments for eye disorders, demonstrating a commitment to improving patient care through research and development.

Latest Patents

Two of his latest patents showcase cutting-edge methodologies in treating eye disorders. The first patent is titled "Methods for treating angiogenic eye disorders with high doses of VEGF receptor fusion proteins." This invention presents ophthalmic formulations that possess high concentrations of vascular endothelial growth factor (VEGF) receptor fusion protein, ensuring stability during storage. These formulations are a promising advancement in addressing angiogenic eye disorders.

The second patent is focused on "Stabilized formulations containing anti-interleukin-6 receptor (IL-6R) antibodies." This invention includes pharmaceutical formulations that utilize human antibodies targeting the human interleukin-6 receptor (hIL-6R). The formulations are designed to sustain a notable degree of antibody stability after several months of storage, enhancing their practicality for therapeutic use.

Career Highlights

Kenneth S. Graham's career is intricately linked to Regeneron Pharmaceuticals, Inc., where he has been instrumental in driving innovation. His work has not only led to numerous patents but has also paved the way for new treatment options in ophthalmology. His dedication to research exemplifies the intersection of science and patient care.

Collaborations

Throughout his career, Kenneth has collaborated with notable professionals, including coworkers Daniel B. Dix and Eric Steven Furfine. These collaborations have fostered a creative environment that has resulted in groundbreaking inventions and further advancements in medical therapies.

Conclusion

Kenneth S. Graham's contributions to ophthalmology through his diverse patents mark him as a leader in the field. His innovative solutions to complex medical challenges and dedication to improving treatment options underscore the vital role of inventors in healthcare. As he continues to work with Regeneron Pharmaceuticals, his impact on both science and patient outcomes is sure to grow.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…